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Abstract
Background: Obesity is a hallmark of aging in many Western societies, and is a precursor to numerous serious age-related
diseases. Ghrelin (Ghrl), via its receptor (growth hormone secretagogue receptor, GHS-R), is shown to stimulate GH secretion
and appetite. Surprisingly, our previous studies showed that Ghrl
-/- mice have impaired thermoregulatory responses to cold
and fasting stresses, while Ghsr
-/- mice are adaptive.
Methodology/Principal Findings: To elucidate the mechanism, we analyzed the complete metabolic profiles of younger (3–
4 months) and older (10–12 months) Ghrl
-/- and Ghsr
-/- mice. Food intake and locomotor activity were comparable for both
null mice and their wild-type (WT) counterparts, regardless of age. There was also no difference in body composition
between younger null mice and their WT counterparts. As the WT mice aged, as expected, the fat/lean ratio increased and
energy expenditure (EE) decreased. Remarkably, however, older Ghsr
-/- mice exhibited reduced fat/lean ratio and increased
EE when compared to older WT mice, thus retaining a youthful lean and high EE phenotype; in comparison, there was no
significant difference with EE in Ghrl
-/- mice. In line with the EE data, the thermogenic regulator, uncoupling protein 1
(UCP1), was significantly up-regulated in brown adipose tissue (BAT) of Ghsr
-/- mice, but not in Ghrl
-/- mice.
Conclusions: Our data therefore suggest that GHS-R ablation activates adaptive thermogenic function(s) in BAT and
increases EE, thereby enabling the retention of a lean phenotype. This is the first direct evidence that the ghrelin signaling
pathway regulates fat-burning BAT to affect energy balance during aging. This regulation is likely mediated through an as-
yet-unidentified new ligand of GHS-R.
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Introduction
Energy homeostasis is determined by the balance between
energy intake and energy expenditure; even small differences over
prolonged time periods in the balance between energy intake and
energy expenditure can result in the development of obesity,
insulin resistance and other serious metabolic disorders. Ghrelin is
an acylated 28-amino-acid peptide predominantly produced by
the X/A-like enteroendocrine cells in the stomach [1], and is the
only known circulating orexigenic hormone. Ghrelin increases
growth hormone (GH) release, stimulates appetite, and induces fat
deposition [2,3,4]. Many studies have suggested that ghrelin plays
a role in long-term body weight regulation, and changes in
circulating ghrelin levels reflect an individual’s nutritional status
[5,6,7]. Ghrelin plays a key role in the regulation of metabolism
and energy homeostasis. The biologically relevant receptor of
ghrelin is a G-protein-coupled receptor named Growth Hormone
Secretagogue Receptor (GHS-R) [8]. By activating GHS-R in the
hypothalamus, ghrelin stimulates orexigenic neurons and pro-
motes preferential ingestion of fat [9,10,11]. Using GHS-R null
mice, we unambiguously demonstrated that GHS-R mediates
ghrelin’s stimulatory effects on GH-release and appetite [12]. In
the last few years, we and others have shown that ghrelin has
effects in tissues that do not express GHS-R; thus there are likely
other ghrelin subtype receptor(s) apart from GHS-R
[13,14,15,16,17]. We recently reported that Ghrl
-/- mice have
impaired abilities to manifest and integrate sleep and thermoreg-
ulatory responses under metabolic challenges induced by cold
temperature and fasting; intriguingly, Ghsr
-/- mice exhibit the
normal responses of their WT counterparts [18]. These observa-
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16391tions suggest that, although GHS-R is a biologically relevant
ghrelin receptor that regulates GH and food intake, ghrelin and
GHS-R also may have independent noncanonical functions, so
that the phenotypes of Ghrl
-/- and Ghsr
-/- mice are different.
There are two types of adipose tissues: energy-storing white
adipose tissue (WAT) and energy-burning brown adipose tissue
(BAT). BAT is primarily responsible for non-shivering thermo-
genesis in rodents and human neonates; it has emerged recently
that variations in BAT activity contribute to differences in energy
expenditure even among adult humans [19]. Thermogenesis in
BAT is achieved by adrenergic-stimulation of both activation and
expression of uncoupling protein 1 (UCP1) in the mitochondria.
UCP1, located in the inner mitochondrial membrane, recruits free
fatty acid (FFA) into the mitochondria to generate heat [20,21].
BAT activity is positively correlated with energy expenditure and
negatively correlated with body fat content [19,22]. BAT is
responsible for more than half of the body’s total oxygen
consumption in small animals; these animals contain proportion-
ately greater amounts of BAT when compared to larger mammals,
including humans. Increased body temperature of about 1uC
could thermodynamically correspond to a 10% increase of
metabolic rate [23]. Dysregulation of adaptive thermogenesis in
BAT has been shown to impact body fat content, and promote
obesity and diabetes [20,24,25].
Aging is associated with a loss of lean mass, and is often
accompanied by an increase of body fat mass which reflects a
positive energy balance leading to weight gain [26]. Furthermore,
aging is associated with diminished thermogenic function; aging
humans have significantly reduced BAT mass and BAT activity
[22,24,27,28,29,30]. This blunted thermogenic response also
contributes to age-associated obesity and energy imbalance.
UCP1 is the key regulator of thermogenesis in BAT. However,
genes which activate UCP1 in BAT are not well characterized,
and there is hardly any information on the genes that age-
dependently regulate thermogenesis.
To further our understanding of the roles of ghrelin and GHS-R
in fat metabolism and energy homeostasis, we have analyzed the
metabolic profiles and BAT thermogenic capacity of our congenic
Ghrl
-/- and Ghsr
-/- mice in detail at both younger and older ages.
Our results showed that older Ghsr
-/- mice maintain a youthfully
lean phenotype, with a decreased percentage of body fat and
increased lean mass; whereas Ghrl
-/- mice do not. Furthermore,
this lean phenotype of older Ghsr
-/- mice is independent of
difference in food intake or physical activity, but is due to higher
energy expenditure. Our data further demonstrated that mito-
chondrial content and thermogenic regulator UCP1 were elevated
in the BAT of the older Ghsr
-/- mice, suggesting increased
thermogenesis. To our knowledge, this is the first study which
shows that GHS-R has a role in thermogenic regulation of energy-
burning BAT in mice. Ghsr ablation enhanced thermogenic
capacity in older mice, but not younger mice, suggesting GHS-
R plays a pivotal role in the aging-related dysfunction of BAT. The
differential metabolic phenotypes revealed by ghrelin- null mice and
Ghsr- null mice show the complexity of ghrelin signaling pathway,
and suggest the possible existence of additional unidentified GHS-
R ligand(s).
Results
Reduced body weights and body fat in older Ghsr
-/- mice,
but not in older Ghrl
-/- mice
To characterize the effects on growth and metabolism of
deficiency in ghrelin- and ghrelin-receptor (GHS-R), we compared
body weights and body compositions of WT, Ghrl
-/- and Ghsr
-/-
mice at ages of 3–4 (younger) and 10–12 (older) months. As
illustrated in Fig. 1A and 1B, there was no significant difference in
body weights between younger null and WT mice, regardless of
genotype. We used quantitative nuclear magnetic resonance
(NMR) to determine the body composition of the mice. There
were no differences among genotypes in body composition at
younger age (Fig. 1C and 1D). There were also no significant
differences in body composition between older Ghrl
-/- mice and
their WT controls (Fig. 1C). In contrast, older Ghsr
-/- mice showed
a statistically significant reduction in body weight and fat mass
compared with WT controls, while the proportion of lean mass
was significantly higher than that of WT mice (Fig. 1B and 1D).
Ghrelin is believed to play important regulatory roles in appetite
and satiety, and it is logical to assume that ghrelin and Ghsr ablation
will lead to decreased food intake. However, regardless of age
there was no difference in the average daily food intake among
WT, Ghrl
-/- and Ghsr
-/- mice (Fig. 1E and 1F). These data suggest
that the lean phenotype of older Ghsr
-/- mice is not likely due to
reduced energy intake (food ingestion).
Ablation of GHS-R leads to marked increases in energy
expenditure and resting metabolic rate in older Ghsr
-/-
mice
Changes in body fat mass occur when there is an imbalance
between energy intake and energy expenditure. Because food
intake was comparable for both Ghrl
-/- and Ghsr
-/- mice compared
to their WT counterparts, a potential explanation for the lean
phenotype of older Ghsr
-/- mice might be an increase in metabolic
rate. We examined the metabolic profiles of younger and older
Ghrl
-/- and Ghsr
-/- mice by using an Oxymax/CLAMS system
(Columbus Instruments, Columbus, OH). To minimize the
confounding effects of stress, mice were caged individually for 1
week and then placed in metabolic cages for at least 4 days before
the indirect calorimetry testing. After 24 h of acclimatization in
the calorimetry chamber, 48 h of indirect calorimetry data were
collected. Both younger Ghrl
-/- and Ghsr
-/- mice had similar energy
expenditure levels compared to their WT counterparts (represen-
tative 24-hr profiles shown in Fig. 2A and 2C). Older mice in both
genotypes showed reduced energy expenditure when compared to
younger mice. The energy expenditure of older Ghsr
-/- mice was
significantly higher than those of WT mice, and the difference
persisted throughout the light and dark phases (Fig. 2D);
meanwhile, older Ghrl
-/- mice failed to show a difference
(Fig. 2B). We also calculated energy expenditure according to
adjusted metabolic body mass (kg
0.75), which represents the
metabolic rate of an animal independent of the size of the body
[31,32]. The adjusted energy expenditure in older Ghsr
-/- mice
remained marked higher than that of WT mice (data not shown).
Additionally, we determined the respiratory exchange ratio (RER)
by indirect calorimetry. There were no differences in RER (Fig.
S1), regardless of age and genotypes; this suggests that neither
ghrelin-ablation nor GHS-R ablation affects fuel substrate
preference under regular chow feeding.
Resting metabolic rate (RMR) is responsible for burning up to
60–70% of total expended calories [33]. We determined the RMR
in these mice to further elucidate whether the differences in total
energy expenditure were primarily due to differences in RMR. We
found that RMR was comparable between Ghrl
-/- and WT mice,
regardless of age (Fig. 3A), but was significantly higher in older
Ghsr
-/- mice compared with their WT counterparts (Fig. 3B).
These data collectively suggest that the lean phenotype of old
Ghsr
-/- mice is primarily contributed by the elevated metabolic
rate.
Ghrelin Signaling and Thermogenesis
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contributed to the higher energy expenditure/metabolic rate of
older Ghsr
-/- mice, we monitored spontaneous locomotor activity
of these mice while in the calorimetry chambers. Neither the total
daily locomotor activity (Fig. 3C and 3D) nor the locomotor
activity during light and dark periods (data not shown) was altered
for Ghrl
-/- or Ghsr
-/- mice when compared to their WT controls,
regardless of age. Again, the data show that increased energy
expenditure of older Ghsr
-/- mice was not due to elevated activity
in these null mice.
Increased mitochondrial content and UCP1 expression in
BAT of older Ghsr
-/- mice
WAT is composed of large adipocytes that store energy in the
form of triglycerides; in contrast, BAT consists of small adipocytes
that contain a reduced amount of triglyceride stored in the form of
multilobular lipid droplets [20]. The BAT adipocytes have a high
mitochondrial density and express the BAT-specific regulator
UCP1. Mitochondrial UCP1 is the hallmark regulator of
mitochondrial biogenesis and thermogenesis; when activated,
UCP1 dissipates the transmembrane proton gradient and
generates heat [34]. The H&E staining of BAT sections of older
Ghsr
-/- mice showed higher percentages of multilobular adipocytes
and increased cellularity (dark blue nuclei) as shown in Fig. 4. To
investigate the mechanism of the increased energy expenditure
observed in the older Ghsr
-/- mice, we further studied the mRNA
expression of UCP1 in BAT of older Ghsr
-/- and Ghrl
-/- mice by
quantitative RT-PCR. Consistent with our calorimetry data, no
difference was observed in BAT of older Ghrl
-/- mice when
compared to that of WT mice (Fig. 5A). Remarkably, however,
Figure 1. Body weight, body composition and daily food intake of WT, Ghrl
-/-, and Ghsr
-/- mice. The data of Ghrelin-null mice are on the
left (A, C, E), and the data for GHS-R-null mice are on the right (B, D, F). (A and B): Both younger and older Ghrl
-/- mice had similar body weight
compared to WT mice, while older Ghsr
-/- mice had significantly lower body weight than WT mice. (C and D): The body composition of Ghrl
-/- mice did
not differ from age-matched WT mice, while older Ghsr
-/- mice showed decreased proportions of body fat and increased proportions of lean mass. (E
and F): The daily food intake of both null mice was comparable to that of their WT controls. The values are presented as mean 6 SEM (n=6–8 per
group); *, P,0.05, null vs. WT mice.
doi:10.1371/journal.pone.0016391.g001
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-/- mice exhibited significantly increased UCP1 mRNA
expression when compared with their WT counterparts (Fig. 5B).
Consistently, Western blots showed that UCP1 protein level was
increased in older Ghsr
-/- mice (Fig. 5C), further supporting the
conclusion of elevated thermogenic function in BAT. We also
demonstrated that mitochondrial DNA content was significantly
increased in older Ghsr
-/- mice as compared to that of WT mice,
indicative of increased mitochondrial content and in line with the
enhanced mitochondrial function in the BAT of older Ghsr
-/- mice.
These data suggest that GHS-R has a novel role in thermogenesis
in BAT, and that GHS-R suppression enhances heat production in
BAT. This may in turn lead to increased fat mobilization and
results in the lean phenotype observed in older Ghsr
-/- mice.
GHS-R ablation improves lipid profiles
Obesity is often correlated with dysregulations of lipid
metabolism, which ultimately leads to insulin resistance, type 2
diabetes and cardiovascular diseases. The lipid levels were similar
between older Ghrl
-/- and WT mice (Fig. 6A). By contrast, in older
Ghsr
-/- mice, total cholesterol and triglycerides levels were
statistically lower compared with WT mice (Fig. 6B). The data
show that ablation of GHS-R improves lipid metabolism. This
suggests that old Ghsr
-/- mice may have healthier outcomes.
Discussion
Pharmacological administration of exogenous ghrelin generates
robust orexigenic effects [4,35,36]. However, paradoxically,
ghrelin levels are lower in obese subjects but higher in lean
subjects [37,38]. The role of endogenous ghrelin in energy
homeostasis remains puzzling. We and others have reported that
when fed a regular chow diet, younger Ghrl
-/- and Ghsr
-/- mice
have normal growth rates, food intake, and body composition,
which are not different from WT controls [39,40,41,42]. When the
mice are fed a high fat diet right after weaning, Ghrl
-/- and Ghsr
-/-
mice appear to prevent diet-induced obesity [41,42]. Interesting,
this protective effect disappears when the high fat diet is fed
starting at an adult age [39]. Animals gain weight as they age due
to increased fat deposition and reduced energy expenditure
[26,43,44,45]. As shown in Fig. 1 of our study, the body weights
and proportions of fat mass of the mice increased as the mice aged.
Consistent with our previous reports, our present study found no
significant difference in body weights among younger (3–4 months
Figure 2. Representative energy expenditure (EE) profiles of WT, Ghrl
-/- and Ghsr
-/- mice. The data for Ghrelin-null mice are on the top (A,
B), and the data for GHS-R null mice are on the bottom (C, D). (A and B): The energy expenditure of neither younger nor older Ghrl
-/- mice differed
from their WT control mice. (C and D): Older Ghsr
-/- mice had a higher energy expenditure when compared with WT mice, whereas there was no
difference in younger mice. The values are presented as mean 6 SEM (n=6–8 per group). *, P,0.05, null vs. WT mice.
doi:10.1371/journal.pone.0016391.g002
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-/-, and Ghsr
-/- mice. By 10–12 months of age,
however, body weights of Ghsr
-/- mice were significantly lower
than those of WT mice, whereas body weights of Ghrl
-/- mice were
still comparable with same-aged WT mice (Fig. 1A and 1B).
During aging, percentage of body fat increases and lean mass
decreases. Using NMR, we examined the impact of ghrelin-
signaling on body composition during aging. Remarkably, older
Ghsr
-/- mice had about 44% less body fat than their WT
counterparts, while the difference in older Ghrl
-/- mice was much
less pronounced (Fig. 1C and 1D). Our data suggest that GHS-R
ablation, but not ghrelin ablation, maintains a youthfully lean
phenotype concurrent with aging.
A number of studies have shown that acute administration of
ghrelin stimulates food intake, and there are ample results to
demonstrate that chronic ghrelin administration resulted in
increased fat deposition [4,36,46]. However, similar to our
previous reports on younger mice [12,40], daily food intake in
older Ghrl
-/- or Ghsr
-/- mice also made no impact on fat deposition
(Fig. 1E and 1F). It is clear that the reduction in body weights and
changes in body fat/lean ratio in older Ghsr
-/- mice are
independent of energy intake (food ingestion).
Imbalance between energy intake (food ingestion) and energy
expenditure (activity and/or heat production) leads to changes in
body composition [47]. A positive energy balance leads to weight
gain, a negative balance results in weight loss, and the weight
being primarily composed of fat. It has been shown that ghrelin is
involved in the regulation of energy expenditure; further, an
inverse relationship exists between ghrelin and energy expenditure
in normal-weight humans [48,49]. Ghrelin induces positive energy
balance by stimulating feeding behavior and suppressing sympa-
thetic nerve activity in BAT [50,51]. Higher levels of ghrelin are
associated with lower levels of resting thermogenesis and
postprandial thermogenesis in humans [52]. However, it is
unknown whether ghrelin’s effect on BAT is mediated through
GHS-R, and whether Ghrl
-/- or Ghsr
-/- mice have similar BAT
phenotypes. As expected, we showed that energy expenditure
decreases as the mice age (Fig. 2). Because there was no difference
in food intake (Fig 1E and 1F), we speculate that the increased
energy expenditure may explain the lean phenotype of older
Ghsr
-/- mice. Indeed, older Ghsr
-/- mice exhibited a pronounced
elevation in energy expenditure, and also maintained an
impressively youthful higher energy expenditure profile when
compared with age-matched WT mice (Fig 2D). Because there was
no difference in activity level (Fig. 3D), this indicates that in older
Ghsr
-/- mice, the increased energy expenditure was primarily due
to increased heat production in BAT. In humans, RMR is lower in
older individuals than in younger individuals, and that is entirely
determined by body composition [53]. Similarly, we detected
decreased RMR in older WT mice, while older Ghsr
-/- mice have a
significantly higher RMR than that of older WT mice, and to
maintain an elevated youthful RMR (Fig. 3B). These data further
support the conclusion that the cause of the lean phenotype in
older Ghsr
-/- mice is due to increased metabolic rate but not due to
changes with appetite or activity.
Figure 3. Resting metabolic rate (RMR) and locomotor activity of WT, Ghrl
-/-, and Ghsr
-/- mice. (A): The RMR was not affected in either
younger or older Ghrl
-/- mice when compared with WT mice. (B): Older Ghsr
-/- mice had a higher RMR compared with WT mice, whereas younger mice
show similar RMR. (C and D): Activity decreases with aging in both mouse models. No significant differences in activity between Ghrl
-/- (C) or Ghsr
-/-
(D) mice compared with their WT control mice. The values are presented as mean 6 SEM (n=6–8 per group); *, P,0.05 null vs. WT mice.
doi:10.1371/journal.pone.0016391.g003
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-/- and Ghsr
-/- mice have decreased
RER values with diet-induced obesity, and indicate that the mice
preferentially metabolize fat as an energy source [41,42].
However, our high fat diet study with our congenic mice did not
show a difference in RER [39]. In our present study of age-
induced obesity, we also did not detect a reduction of RER (Fig.
S1). We conclude that ghrelin and GHS-R are not determining
factors for fuel preference when regular chow is fed.
BAT plays an important role in energy metabolism, and
thermogenic activation of BAT can directly affect metabolic rate.
Activation of BAT function is correlated with increased mito-
chondrial content and activity [54]. We observed that there is no
difference in morphology between younger and older Ghrl
-/- mice,
whereas the BAT of older Ghsr
-/- mice has an increased abundance
of multilobular adipocytes (Fig. 4) and higher mitochondrial DNA
content in the BAT of old Ghsr
-/- mice (Fig. 5D). Also, we detected
increased cellularity (dark blue nuclei), which suggests that deletion
of GHS-R promotes adipogenesis in BAT (Fig. 4). These are all in
support of enriched mitochondrial content.
UCP1 is a key regulator of thermogenesis, which allows protons
to enter the mitochondrial matrix and dissipates energy as heat in
preference to the energy being used for ATP production [20,21].
Consistent with this histological evidence, we have shown increased
UCP1 mRNA and protein expression in the BAT of older Ghsr
-/-
mice (Fig. 5B and 5C), but not in older Ghrl
-/- mice. Thus, our data
show that Ghsr
-/- mice, but not Ghrl
-/- mice, have enhanced
mitochondrial activity. Our data collectively showed increased
mitochondrial content and enhanced mitochondrial activity in the
BAT of older Ghsr
-/- mice; this may in turn elevate thermogenesis
and attenuate the age-associated decline of thermogenic function.
We previously showed that GHS-R expression was not detected
in brown adipose tissues of younger mice [55]. Interestingly, our
new data show lower level of GHS-R is expressed in BAT of older
mice (unpublished data). We have seen increased circulating
ghrelin levels during aging [55], which suggest age-related ‘‘ghrelin
resistance’’ in older animals. The differential expression patterns in
younger versus older mice suggest that GHS-R may be ‘‘turned
on’’ specifically in BAT during aging, and may directly regulate
the function of BAT. Animal models of fat depot-specific deletion
of GHS-R, and/or GHS-R inducible systems turned on during
aging, may provide further direct evidence as to whether GHS-R
is a key regulator in fat metabolism during aging.
In rodents, it has been shown that BAT may have protective
effects during aging. Calorie restriction (CR) is known to have
beneficial effects on health and longevity. It has been shown that
CR prevents the age-related declines in mitochondrial mass,
cyclooxygenase activity and uncoupling levels in BAT of rats [56].
Our data showed that ablation of GHS-R increases thermogenic
capacity in BAT, as well as energy expenditure; the increased
energy demand created by this enhanced metabolic activity in
BAT would support increased fat mobilization, and result in the
reduction of body weight. Obesity has many significant deleterious
consequences, including lipid dysregulation. We detected an
improved lipid profile in older Ghsr
-/- mice (Fig. 6), which further
supports the conclusion that older Ghsr
-/- mice have a healthier
lean phenotype during aging which placed them at lower risk for
diabetes and cardiovascular disease. It is possible that GHS-R is
involved in mediating a CR-induced beneficial metabolic state via
BAT thermogenesis. Moreover, the inhibition of GHS-R may
unravel the beneficial effects of CR on longevity without dieting or
Figure 4. Morphology of interscapular brown adipose tissue (BAT) of older WT, Ghrl
-/-, and Ghsr
-/- mice. (A): The morphology was very
similar between older Ghrl
-/- and their WT counterparts. (B): BAT of older Ghsr
-/- mice showed higher percentages of multilobular adipocytes and
increased cellularity (dark blue nuclei). These are representative H & E staining of BAT paraffin sections from 4–8 mice.
doi:10.1371/journal.pone.0016391.g004
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demonstrate that GHS-R regulates thermogenesis in BAT, thus
providing the first evidence that GHS-R regulates BAT thermo-
genesis, suggesting that GHS-R antagonism may have protective
effects against age-induced obesity.
The phenotype we observed in Ghsr
-/- mice could result from
GHS-R-mediated effects in central, peripheral and/or hormonal
levels. Thyroid hormones are important regulators of RMR and
thermogenesis [57,58]. However, serum T3 and T4 levels were
comparable in WT and Ghsr
-/- mice (unpublished data), suggesting
that the elevated RMR of older GHS-R null mice is not due to
changes in circulating thyroid hormones; nevertheless, we cannot
preclude the possibility of enhanced thyroid hormone activity in
Ghsr
-/- mice locally, at the hypothalamic level [59]. GH is another
Figure 5. UCP1 expression and mitochondrial DNA content in BAT of older mice. Relative quantitative RT-PCR was used for mRNA analysis,
and the expression of average value of WT was defined as 1. (A): UCP1 mRNA expression was not affected in Ghrl
-/- mice. (B): UCP1 mRNA level was
increased in BAT of Ghsr
-/-mice compared with WT counterparts. (C): UCP1 protein was increased in the BAT of older Ghsr
-/- mice. Sample Western
blots on top and quantization at the bottom. (D) Ghsr
-/- mice had increased mitochondrial DNA content in BAT compared with that of WT mice. The
values are presented as mean 6 SEM (n=9–12 per group); *, P,0.05 null vs. WT mice.
doi:10.1371/journal.pone.0016391.g005
Figure 6. Fasting lipid profile in older WT, Ghrl
-/- and Ghsr
-/- mice. (A): Lipid levels were not different between WT and Ghrl
-/- mice. (B): Levels
of total cholesterol (CHOL) and triglycerides (TG) were significantly decreased in Ghsr
-/- mice compared with WT counterparts. The values are
presented as mean 6 SEM (n=9–12 per group); *, P,0.05 null vs. WT mice.
doi:10.1371/journal.pone.0016391.g006
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strong inverse association between visceral fat accumulation and
blunted GH secretion in adults [60,61]. GH is the primary
regulator of IGF-1. We previously showed that GHS-R mediates
the GH stimulatory effects of ghrelin, so it was expected when
older Ghsr
-/- mice showed reduced IGF-1 (Fig. S2). It was
surprising, however, that IGF-1 levels in older Ghrl
-/- mice were
unchanged when compared to that of WT mice. The reduced
IGF-1 level suggests that GH is likely decreased in the older Ghsr
-/-
mice, but it cannot explain the lean phenotype. We thus conclude
that neither thyroid hormone nor the GH signaling pathway is
likely to be mediating the adipose phenotype.
It is intriguing that we have observed differential thermogenic
phenotypes in older Ghsr
-/- and Ghrl
-/- mice. Even though GHS-
R is considered a physiologically relevant receptor for ghrelin,
our current data of differential metabolic phenotypes of older
Ghrl
-/- and Ghsr
-/- mice challenges current dogma. Our study
adds to the increasing body of literature that there is another as-
yet-unidentified GHS-R ligand(s) besides ghrelin that regulate
thermogenic function in BAT. Three peptides are derived from
the preproghrelin gene: ghrelin (acylated ghrelin), des-acyl
ghrelin and obestatin [62]. Acylated ghrelin, which contains an
n-octanoic acid at the third Ser residue, activates GHS-R. In
contrast, des-acyl ghrelin and obestatin do not activate this
receptor. Since des-acyl ghrelin does not activate GHS-R, it
initially was thought to be biologically inactive. Subsequent
studies demonstrated that in addition to acylated ghrelin, des-acyl
ghrelin also stimulates lipid accumulation in human visceral
adipocytes [63]. Furthermore, both acylated ghrelin and des-acyl
ghrelin have adipogenic effects in bone marrow, while a synthetic
GHS-R agonist does not; this suggests that acylated ghrelin and/
or des-acyl ghrelin activate receptors other than GHS-R [64]. We
have shown that des-acyl ghrelin has ghrelin-like effects on
feeding which are independent of the activation of GHS-R, and is
mediated through orexin [15]. In contrast to ghrelin, obestatin
suppresses appetite and enhances energy expenditure [62] and
has a leptin-like role in the regulation of metabolism [65,66,67].
It was reported that chronic treatment of ghrelin decreases UCP1
expression in BAT [68]; but it is unknown whether the effect is
mediated through GHS-R. We recently reported that Ghrl
-/-
mice, but not Ghsr
-/- mice, are hypothermic under cold and
fasting stress; intriguingly, obestatin attenuates the hypothermic
response of Ghrl
-/- mice [18]. Our Ghrl
-/- mice have neither
ghrelin nor obestatin. On the other hand, Ghsr
-/- mice have
ghrelin and obestatin, but only ghrelin signaling is blocked in
these mice. Our ghrelin-null has a BAT phenotype different from
that of Ghsr-null mice, which invites the questions: Whether
ghrelin and obestatin have opposite thermogenic effects on BAT?
Whether the BAT phenotype of Ghsr
-/- mice can be explained by
unopposed effect of obestatin? These observations highlight the
complexity of the ghrelin signaling pathway, further investigation
is needed.
In conclusion, our study demonstrates differential effects for
deficiency of ghrelin- and GHS-R on body composition and
energy homeostasis during aging. The decrease of body fat and
increase of lean mass in older Ghsr
-/- mice are independent of food
intake or activity; they are due to increased energy expenditure
might be resulted from enhanced thermogenic capacity in BAT.
Our data demonstrate for the first time that GHS-R regulates fat-
burning BAT to regulate adiposity and metabolism without
affecting energy intake or activity. Thus, GHS-R plays an
important role in energy homeostasis during aging, and GHS-R
antagonists may be a paradigm-shifting new class of drugs that can
prevent age-associated obesity.
Materials and Methods
Animals
All procedures used in animal experiments were approved by
the Institution of Animal Care and Use Committee at Baylor
College of Medicine. The generation of Ghrl
-/- and Ghsr
-/- mice
has been previously described [12,40]. All mice were on a pure
C57BL/6J background, and have been backcrossed to C57BL/6J
for 13 generations. Mice were maintained under conditions of
controlled temperature (,75uF) and illumination (12-hour light/
12-hour dark cycle, 6am to 6pm) with free access to water and
regular mouse chow (TD. 2920X, 16% of calories from fat, 60%
from carbohydrates, 24% from protein, Harlan Teklad, Madison,
WI). Age-matched male Ghrl
-/-, Ghsr
-/- and their WT controls were
used in the studies; mice were 3-4 months old (younger group) and
10–12 months old (older group). The amount of food consumed
was monitored daily for 1–2 weeks in a Comprehensive
Laboratory Animal Monitoring System (Columbus Instruments,
Columbus, OH). All procedures used in animal experiments were
approved by the Institution of Animal Care and Use Committee at
Baylor College of Medicine.
Body composition and indirect calorimetry
Whole-body composition (fat and lean mass) of Ghrl
-/-, Ghsr
-/-
and WT mice was measured by an Echo MRI-100 whole-body
composition analyzer (Echo Medical Systems, Houston, TX).
Metabolic parameters were obtained by using an Oxymax
(Columbus Instruments, Columbus, OH) open-circuit indirect
calorimetry system for 72 h. The first 24 h was considered the
acclimation phase, and data were analyzed only for the final 48 h.
Mice were individually caged in chambers and given free access to
regular chow and water for 1-week prior to the tests. Oxygen
consumption (VO2) (ml/h), carbon dioxide production (VCO2)
(ml/h), and locomotor activity (beam break counts) were
measured. Respiratory exchange ratio (RER) and energy expen-
diture (EE, or heat generation) were calculated from VO2 and
VCO2 gas exchange data as follows: RER= VCO2/VO2 and
EE= (3.815+1.2326RER) 6VO2 [69]. Energy expenditure was
then normalized to body weight. Locomotor activity was measured
on x- and z-axes using infrared beams to count the number of
beam breaks during the recording period. Resting metabolic rate
(RMR) for each mouse was determined by averaging of lowest
plateau region of energy expenditure curve corresponding to
resting periods, as previously described [70].
Histological analysis
BAT was fixed overnight in 10% formalin at room temperature,
dehydrated and embedded in paraffin. Then tissue blocks were
sectioned at 5 mm for H&E staining. The H&E staining was
carried out following the standard protocols [71].
Analysis of gene expression
BAT was snap-frozen in liquid nitrogen and stored at 280uC.
Total RNA was extracted from frozen tissue samples using TRIzol
Reagent (Invitrogen, Carlsbad, CA). RNA was subsequently
treated with DNase (Ambion, Austin, TX) and its integrity was
assessed by performing 1.5% agarose gel electrophoresis in the
presence of formaldehyde; its concentration was determined by
NanoDrop. RNA was reverse-transcribed using Superscript III
First Strand Synthesis System (Invitrogen, Carlsbad, CA).
Quantitative RT-PCR was performed in triplicate, as previously
described [72]. Mouse UCP1 gene-specific primers were obtained
from Applied Biosystems (Mm00494070_m1). 18S and b-actin
were used as the housekeeping controls. Relative levels of UCP1
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Western blot analysis
Tissues were lysed in RIPA buffer with complete protease
inhibitor cocktail (Roche Inc.). Protein concentration was
determined with BCA protein assay kit (Pierce, Rockford, IL).
Twenty microgram protein of each sample was separated by SDS-
PAGE and electro-transferred to nitrocellulose membrane for
immunoblot analyses. The following antibodies were used: anti-
UCP1 (Millipore, 1:1,000), anti-b-actin (Santa Cruz Biotechnol-
ogy, 1:1,000), HRP-conjugated anti-mouse (GE Healthcare UK
Limited, 1:10,000), anti-rabbit (GE Healthcare UK Limited,
1:10,000). The SuperSignal West Pico Chemiluminescent kit
(Pierce) was used for the Westerns.
Extraction and quantification of mitochondrial DNA
Mitochondrial DNA (mtDNA) was extracted and quantified as
described with modification [73]. Briefly, interscapular BAT was
dissected and homogenized in isolation buffer (300 mM sucrose,
1 mM EDTA, 5 mM MOPS, 5 mM KH2PO4, 0.01% BSA,
pH 7.4) with a glass homogenizer. The homogenate was first
filtered through a layer of gauze. Nuclear and cell debris fraction
was isolated by centrifugation at 800 g for 10 min at 4uC. The
resulting supernatant was subjected to centrifugation at 8,000 g for
10 min at 4uC. Aliquots of the nuclear and mitochondrial fractions
were digested overnight in lysis buffer (10 mM Tris, pH 8.0,
10 mM EDTA, 10 mM NaCl, 0.5% SDS, 100 mg/ml Proteinase
K) at 37uC. Nuclear and mitochondrial DNA was extracted using
the phenol/chloroform method. Nuclear DNA was quantified by
NanoDrop (ND-1000 Thermo Scientific). Mitochondrial DNA
was linearized by digestion with Bcl-I for 3 h at 50uC, and then
boiled for 5 min. Samples were centrifuged at 7,000 g for 5 min,
and the resulting supernatant was used for subsequent PCR
amplification. PCR was performed to amplify a 162-nt region of
the mitochondrial NADH dehydrogenase. The primer sequences
were 59-TACACGATGAGGCAACCAAA-39 and 59-GGTAG-
GGGGTGTGTGTTGTGAG-39. The amplified PCR product of
mtDNA and total DNA were quantified by spectrometry
(NanoDrop), and the ratio of mtDNA/total DNA was calculated.
Plasma analysis
Plasma samples were obtained by low-speed centrifugation of
blood samples from 24 h-fasted mice. The assay kits were supplied
by Roche Diagnostics Corporation, (Indianapolis, IN). Cholesterol
and triglyceride were determined by enzymatic colorimetric
methods; LDL, HDL, and VLDL were determined by homoge-
neous enzymatic colorimetric methods.
Supporting Information
Figure S1 Respiratory exchange ratio (RER) of younger
and older WT, Ghrl
-/-, and Ghsr
-/- mice. (A and B): The
RER of Ghrl
-/- mice did not differ from WT mice in either younger
or older groups. (C and D): Both younger and older Ghsr
-/- mice
show similar RER compared with WT mice. The values are
presented as mean 6 SEM (n=6–8 per group).
(TIF)
Figure S2 Plasma IGF-1 levels in older WT, Ghrl
-/- and
Ghsr
-/- mice. Plasma IGF-1 levels were similar in WT and
Ghrl
-/- mice (A), whereas older Ghsr
-/- mice showed significantly
decreased IGF-1 levels when compared with their WT controls
(B). The values are presented as mean 6 SEM (n=7–13 per
group); *, P,0.05 null vs. WT mice.
(TIF)
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